• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
    • Cardiovascular
    • Orthopedics
  • Wall Street Beat
    • Funding Roundup
    • Mergers & Acquisitions
  • Podcasts
    • MPR: Breakthrough Products Series
  • Resources
    • About MassDevice
    • Newsletter Signup
    • Job Board
    • Leadership in Medtech
    • Manufacturer Search
    • MedTech 100 Index
    • Videos
    • Whitepapers
  • DeviceTalks Tuesdays
    • DeviceTalks
  • Coronavirus: Live updates

Cerapedics Inc.

Cerapedics launches P-15L peptide-enhanced bone graft IDE trial

July 30, 2018 By Fink Densford

Cerapedics said today it launched a new investigational device exemption trial looking to explore the safety and efficacy of its next-gen P-15L peptide enhanced bone graft in transforaminal interbody fusion surgeries. The Westminster, Colo.-based company said it has enrolled the first patients in the study, which aims to enroll a total of 364 patients with degenerative […]

Filed Under: Clinical Trials, Orthopedics Tagged With: Cerapedics Inc.

Cerapedics raises $22m

July 16, 2018 By Fink Densford

Cerapedics said late last week it closed a $22 million round of financing and added three new members to its board of directors The funding round was led by family investment fund KCK Group, the Westminster, Colo.-based company said, and will help support the company’s bone graft products. “We are pleased to announce that we have […]

Filed Under: Business/Financial News, Orthopedics Tagged With: Cerapedics Inc.

Cerapedics wins FDA IDE nod for P-15L bone graft trial

March 14, 2018 By Fink Densford

Cerapedics said today it won FDA investigational device exemption approval to launch a clinical trial examining the safety and efficacy of its P-15L Peptide Enhanced bone graft. In the trial, the Wesminster, Colo.-based company will explore the use of the P-15L graft as it compares to autografts in transforaminal lumbar interbody fusion procedures meant for treating […]

Filed Under: Clinical Trials, Food & Drug Administration (FDA), Regulatory/Compliance, Spine Tagged With: Cerapedics Inc.

Cerapedics touts IDE bone graft trial results

February 4, 2016 By Fink Densford

Cerapedics today released the results from the pivotal FDA investigational device exemption trial of its i-Factor peptide enhanced bone graft for use in anterior cervical discectomy and fusion procedures. Data from the study was published electronically in the journal Spine. The Westminster, Colo.-based company said the trial demonstrated appropriate safety and efficacy and met all 4 […]

Filed Under: Clinical Trials, Spine Tagged With: Cerapedics Inc.

Cerapedics wins FDA nod for I-Factor cervical bone graft

November 4, 2015 By Fink Densford

Cerapedics said yesterday it won FDA premarket approval for its I-Factor peptide enhanced bone graft for use in anterior cervical discectomy and fusion procedures for patients with degenerative cervical disc disease. Westminster, Colo.-based Cerapedics said the I-Factor graft is the 1st bone graft approved for use in cervical spine procedures and the 2nd PMA cleared bone […]

Filed Under: Food & Drug Administration (FDA), Pre-Market Approval (PMA), Regulatory/Compliance, Spine Tagged With: Cerapedics Inc.

ForSight Vision5 pulls down a $15 million Series C round | Medtech funding stories for the week of Apr. 21, 2014

April 25, 2014 By MassDevice Leave a Comment

ForSight Vision5 lands $15M Series C round

April 18, 2014 by Brad Perriello

ForSight Vision5 lands $15M Series C round

Filed Under: Funding Roundup, News Well Tagged With: Baxano Surgical, Cerapedics Inc., ForSight Vision, GE Healthcare, National Venture Capital Assn. (NVCA), PricewaterhouseCoopers (PwC), Sotera Wireless, Thomson Reuters

GE gets behind Cerapedics and its i-FACTOR bone graft

April 21, 2014 By Arezu Sarvestani Leave a Comment

GE gets behind Cerapedics and its i-FACTOR bone graft

Tech and healthcare giant GE (NYSE:GE) put some skin in Cerapedics and its i-FACTOR bone graft, funding a $9 million venture debt financing round for the Colorado-based company.

Filed Under: Funding Roundup, News Well Tagged With: Cerapedics Inc., GE Healthcare, Orthobiologics, Resorbable bone materials

ConforMIS lures Zimmer ops director to be its new operations SVP | Personnel Moves

May 16, 2013 By Brad Perriello Leave a Comment

ConforMIS lures Zimmer ops director to be its new COO

ConforMIS lured Zimmer’s dental business operations director, Matthew Scott, away to be its new chief operating officer as it looks to scale up its customized knee implant business.

The Bedford, Mass.-based medical device company said Scott bring’s a decade’s worth of ops experience from his tenure at Zimmer. ConforMIS makes knee replacement implants and instrumentation that are custom-fit to patients’ morphology.

Filed Under: Implants, News Well, Orthopedics Tagged With: Cerapedics Inc., conformis, Harvard Bioscience Inc., Knees, Novartis, Orthofix, Personnel Moves, wrightmedical, Zimmer Biomet

Cerapedics raises $19M in Series C round

December 12, 2012 By MassDevice staff Leave a Comment

Cerapedics

Cerapedics said it closed a Series C equity round worth $19 million, led by new investors MedImmune Ventures and CVF LLC, an affiliate of Henry Crown & Co.

Existing backers OrbiMed Advisors and NGN Capital also participated, according to a press release.

Filed Under: Funding Roundup, News Well, Spine Tagged With: Cerapedics Inc., Orthobiologics

The Dow flirts with 13,000 | Wall Street Beat

February 22, 2012 By MassDevice staff Leave a Comment

MassDevice.com Wall Street Beat

The Dow Jones Industrial Average, a longtime bellwether for the U.S. economy, flirted yesterday with a high-water mark not seen since Lehman Brothers’ collapse triggered an economic implosion more than 4 years ago.

The Dow reached 13,005.04 at one point yesterday, before subsiding to close at 12,965.69 yesterday. It’s the first time the index has climbed that high since May 2008.

Investors were heartened by a deal struck in the European Union to resolve Greece’s debt crisis and by positive earnings results from a pair of American stalwarts.

Filed Under: Funding Roundup, News Well, Wall Street Beat Tagged With: Cerapedics Inc., Dentsply Sirona, Dow Jones, Group Purchasing Organizations (GPO), InVivo Therapeutics, SafeStitch Medical, Teleflex, Vascular Magnetics

Covidien completes enrollment on ev3 atherectomy device study | Research roundup

April 11, 2011 By MassDevice staff Leave a Comment

Covidien

Covidien plc (NYSE:COV) said it has enough patients to evaluate the effectiveness of an arterial plaque removal system it acquired in its buyout of ev3 Inc. last year.

Filed Under: News Well Tagged With: American Heart Assn., Baxter, Cerapedics Inc., Clinical Trials, Covidien, Durect Corp., ev3 Inc., Masimo, NewCardio Inc., Orthovita Inc.

Primary Sidebar

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Need Medtech news in a minute?
We Deliver!

MassDevice Enewsletters get you caught up on all the mission critical news you need in med tech. Sign up today.

Tweets by @MassDevice
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion

MASSDEVICE

Subscribe to MassDevice
Advertise with us
About
Contact us

Add us on Facebook Follow us on Twitter Connect with us on LinkedIn Follow us on YouTube

Copyright © 2021 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Advertise | Privacy Policy | RSS